BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.82
0.32%
US Tech 100
20,240.00
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.4012
-0.11%
Bitcoin
95,686.34
-0.30%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. Argenica Therapeutics Limited (AGN)

  7. Argenica Therapeutics Limited (AGN) Financials

Argenica Therapeutics Limited

Argenica Therapeutics Limited (AGN)

Algernon Pharmaceuticals Inc
Aegon Ltd
0.645
0.00
(0.00%)
Closed November 28 11:00PM
Delayed by 20 minutes

Argenica Therapeutics Limited Financial Summary

The current AGN market cap is 79.22M. The company's latest EPS is AUD -0.0446 and P/E is -14.35.

Income Statement

Year End June 29 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 0296k259k1.75M2.6M
Operating Income 0-614k-4.09M-4.88M-5.67M
Net Income 0-1.03M-4.09M-4.82M-5.48M

Balance Sheet

Year End June 29 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 7.52M7.27M9.04M9.54M16.38M
Total Liabilities 58k426k736k1.87M2.43M
Total Equity 7.46M6.85M8.31M7.67M13.95M

Cash Flow

Year End June 29 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Operating N/A -1.05M-3.36M-3.3M-5.06M
Investing N/A N/A N/A -50k50k
Financing N/A 7.85M5.13M3.73M11.64M

Stats and Ratios

Market Cap 79.22M
Price to Earnings Ratio -14.35
Price to Sales Ratio 30.19
Price to Cash Ratio 4.94
Price to Book Ratio 5.63
Dividend Yield -

Share Statistics

Shares Outstanding 122.82M
Average Volume (1 week) 129.99k
Average Volume (1 Month) 137.55k
52 Week Change 51.76%
52 Week High 0.985
52 Week Low 0.415
Spread (Intraday) 0.03 (4.41%)

Company Info

Company Name Argenica Therapeutics Limited
Address unit 4
nedlands, western australia 6009
Website https://
Industry pharmaceutical preparations (2834)
ADVFN Logo
InvestorsHub

Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49